1. Home
  2. LOCO vs BNTC Comparison

LOCO vs BNTC Comparison

Compare LOCO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo El Pollo Loco Holdings Inc.

LOCO

El Pollo Loco Holdings Inc.

HOLD

Current Price

$14.34

Market Cap

456.5M

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$10.79

Market Cap

396.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOCO
BNTC
Founded
1980
1995
Country
United States
United States
Employees
N/A
24
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.5M
396.3M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
LOCO
BNTC
Price
$14.34
$10.79
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$14.17
$27.67
AVG Volume (30 Days)
170.8K
99.5K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
4.65
6.67
EPS
0.70
N/A
Revenue
$401,701,000.00
N/A
Revenue This Year
$3.60
N/A
Revenue Next Year
$3.98
N/A
P/E Ratio
$20.30
N/A
Revenue Growth
5.68
N/A
52 Week Low
$8.99
$9.85
52 Week High
$17.40
$16.76

Technical Indicators

Market Signals
Indicator
LOCO
BNTC
Relative Strength Index (RSI) 36.48 35.19
Support Level $13.52 $10.04
Resistance Level $14.38 $14.14
Average True Range (ATR) 0.37 0.65
MACD -0.08 -0.17
Stochastic Oscillator 14.23 8.56

Price Performance

Historical Comparison
LOCO
BNTC

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: